openPR Logo
Press release

Corneal Neovascularization Market Forecast to 2024 with Share & Growth Projections in Key Product Segments

03-01-2017 02:07 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Corneal Neovascularization Market Forecast to 2024 with Share &

Global Corneal Neovascularization Market: Outlook

Corneal neovascularization is a disorder of the eyes, which is mainly characterized by the incursion of novel blood vessels into the cornea of the individuals suffering from the disease. This disorder is majorly caused due to disruption of the balance between the factors that protects and maintain the corneal transparency. The two factors that need to be balanced include angiogenic and antiangiogenic factors. The incursion of new blood vessels, which are relatively immature, hence can cause lipid exudation as well. Other major symptoms include scarring in eyes, persistent inflammation, which leads to diminishing corneal transparency and visual perception. The corneal neovascularization disorders if left untreated it may lead to high growth of new blood vessels that may reach visual axis to permanently threat the vision of the affected individual. Presently, several patients suffering from various eye problems, many a times undergo corneal grafts; corneal neovascularization may lead to rejection of such grafts as well. Thus, timely and proper treatment (may include surgical intervention and therapeutic drugs) of corneal neovascularization is necessary for effective management of the disease to ensure proper eye vision.

Get Sample Research Report @: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17270

Global Corneal Neovascularization Market: Drivers and Restraints

Major driving factors for the growth of corneal neovascularization market include increasing incidences of ophthalmic disorders, rising number of corneal grafts, aging population, increasing obesity rate, increasing number of diseases such as diabetes and hypertension and increasing demand for advanced treatment options. Ophthalmic disorders are one of the leading disorders that affect very large population globally; several eye related disorders require ophthalmic interventions that may increase the risk of developing corneal neovascularization, hence accompanied by graft rejections. Increasing geriatric population will also contribute towards the growth of this market as aged individuals are more prone to several disorders and hence, tend to suffer from ophthalmic disorders. Increasing obesity rates are also adding to various eye related disorders mainly the lipid deposition increase the chances of developing corneal neovascularization, hence will contribute towards the growth of this market. Several diseases like diabetes, hypertension and others also lead to ophthalmic diseases, in turn require diagnostics and therapeutics from this market, thus will contribute towards the growth of corneal neovascularization market. Several pharmaceutical companies are having many therapeutic drugs for the effective treatment of this disorder in different phases of clinical trials, which will soon hit the market.

Global Corneal Neovascularization Market: Regional Analysis

Geographically, North America and Europe are expected to dominate the corneal neovascularization market. Major factors responsible for their expected dominance in the corneal neovascularization market are high prevalence of ophthalmic disorders in the region, aging population, rising overweight as well obese population, and high awareness levels of the population. However, emerging economies like China, India, Brazil, Mexico, Russia, and Malaysia among others from Asia-Pacific, LATAM, Middle East and other regions will present tremendous opportunities towards the growth of this market. Major factors responsible for the growth of the corneal neovascularization market in these regions are availability of high patient population, high prevalence of diseases like diabetes and hypertension, increasing healthcare awareness in these regions and increasing purchasing power of the people in APAC and RoW.

Browse Full Report @: http://www.transparencymarketresearch.com/corneal-neovascularization-market.html

Global Corneal Neovascularization Market: Companies Mentioned in the Report

Some of the major players operating in this market include, Amakem NV, F. Hoffmann-La Roche Ltd., GTx, Inc., and Sirnaomics, Inc. that have their drugs in different phases of clinical trials, which will soon be commercialized in the global corneal neovascularization market.

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Corneal Neovascularization Market Forecast to 2024 with Share & Growth Projections in Key Product Segments here

News-ID: 453680 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Corneal

Corneal Topographers Market Development, Trends, Segmentations Analysis
Transparency Market Research (TMR) has published a new report on the corneal topographers market for the forecast period of 2019-2027. • According to the report, the global corneal topographers market was valued at ~US$ 920 Mn in 2018, and is projected to expand at a CAGR of 5% from 2019 to 2027. The global corneal topographers market is driven by an increase in the awareness and acceptance of corneal topographers due to
01-21-2022 | Health & Medicine
SDKI
Artificial Corneal and Corneal Implant Market 2022 Industry Key Player, Trend an …
SDKI Inc. aims to provide a detailed analysis of several aspects of the market, including market growth drivers, opportunities, recent trends and challenges between 2021 and 2026. The artificial corneal and corneal implant market. Report sample URL https://www.sdki.jp/sample-request-112023 The global artificial corneal and corneal implant market is estimated to reach US $ 599 million by 2026 from US $ 418 million in 2021 and is projected to grow at a CAGR of 7.4%
Corneal Implants Market - Major Factors Driving the Industry
Corneal Implants Market: An Overview The global corneal implants market is expected to witness a stellar growth during 2018-2028. This is mainly attributed to the increasing cases of eye sight related problem in the people owing to sedentary lifestyle. Corneal implant is newly introduced technique to improve cornea thus improve eye sight of the patients suffering from keratoconus. The adoption of new technique has helped in improve corneal diseases thereby eliminating risk
Corneal Topography Market share and Scope by 2024
New York, February 25, 2019: Market Research Engine has published a new report titled as “Corneal Topography Market Size, By Product Type (Integrated System (with pc), Corneal Topographer (without pc integrated)), By Application/End-User (Hospital, Clinic), By Region, Market Analysis Report, Forecast 2018-2024.” The Corneal Topography Market is segmented on the lines of its product, application, end-user and regional. Based on product segmentation the global Corneal Topography market splits into Integrated system
Global Corneal Pachymetry Market Research Report 2017
Report Hive Market Research Released a New Research Report of 110 pages on Title " Global Corneal Pachymetry Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. Corneal pachymetry is the way toward measuring the thickness of the cornea. A pachymeter is a restorative gadget used to gauge the thickness of the eye's cornea. It is utilized to perform corneal pachymetry preceding refractive surgery, for Keratoconus screening, LRI surgery and
Corneal Neovascularization Market: Current trends/opportunities/challenges
Global Corneal Neovascularization Market: Outlook Corneal neovascularization is a disorder of the eyes, which is mainly characterized by the incursion of novel blood vessels into the cornea of the individuals suffering from the disease. This disorder is majorly caused due to disruption of the balance between the factors that protects and maintain the corneal transparency. The two factors that need to be balanced include angiogenic and antiangiogenic factors. The incursion of